Home Jillian Russyll (AKA Jill) Tate
Article Publicly Available

Jillian Russyll (AKA Jill) Tate

  • Mario Plebani EMAIL logo , Philippe Gillery , Heike Jahnke , Karl Lackner , Giuseppe Lippi , Bohuslav Melichar , Deborah A. Payne and Peter Schlattmann
Published/Copyright: December 25, 2018

With deep sorrow we announce that on December 4, 2018 we have lost a good friend, a nice colleague, an esteemed scientist and an Associate Editor of Clinical Chemistry and Laboratory Medicine.

Jill Tate died after a long illness which she faced with courage and endurance. Although the disease did not allow her to work so hard in the last few months as she did throughout her career, she expressed her joy in assisting with the publication of the special issue on “Harmonization in Laboratory Medicine: the Request, the Sample, the Measurement, and the Report” which was conceived, managed and published only thanks to Jill’s enthusiastic and devoted work.

Jill, in fact, was the Chair of the Australasian Association of Clinical Biochemists’ Harmonisation Committee and worked on a wide range of harmonization activities, including common reference intervals, standardized measurement units, terminology and reporting in laboratory medicine, as well as critical results notification, activities which are now universally recognized as “the global picture of harmonization in laboratory medicine”.

Although Jill worked as a Senior Scientist at the Pathology Queensland Department of Chemical Pathology at the Royal Brisbane and Women’s Hospital in Brisbane, her invaluable contribution to the advancement of laboratory medicine needs to be acknowledged.

Jill chaired the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Working Group for the Standardization of Cardiac Troponin I (IFCC WG-TNI), and previously participated in the IFCC Committee on Standardization of Markers of Cardiac Damage and the IFCC Working Group on Standardization of Lipoprotein(a).

Along with dozens of other papers in leading journals, she published several seminal papers, including those on interference in immunoassays [1], measurement uncertainty [2], standardization of cardiac troponin I immunoassays [3], reporting of serum protein electrophoresis to clinicians [4], and many other innovative and interesting articles.

We wish to particularly recall that she was, and she will remain, an archetype for many laboratory professionals because, along with her exceptional competency and expertise, she was always humble and supportive during her lifetime devoted to science in the service of humanity. She will be remembered with love, affection and respect by all those who knew her, especially by her friends and colleagues.


Corresponding author: Professor Mario Plebani, Department of Laboratory Medicine, University-Hospital of Padova, 35128 Padova, Italy, Phone: +390498212792, Fax: +39049663240

References

1. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev 2004;25:105–20.Search in Google Scholar

2. Tate JR, Plebani M. Measurement uncertainty – a revised understanding of its calculation and use. Clin Chem Lab Med 2016;54:1277–9.10.1515/cclm-2016-0327Search in Google Scholar PubMed

3. Panteghini M, Bunk DM, Christenson RH, Katrukha A, Porter RA, Schimmel H, et al. Standardization of troponin I measurements: an update. Clin Chem Lab Med 2008;46:1501–6.10.1515/CCLM.2008.291Search in Google Scholar PubMed

4. Tate JR, Mollee P, Gill D. The reporting of serum protein electrophoresis to clinicians. Clin Chim Acta 2005;358:204–5.10.1016/j.cccn.2005.04.010Search in Google Scholar PubMed

Published Online: 2018-12-25
Published in Print: 2018-12-19

©2019 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Obituary
  3. Jillian Russyll (AKA Jill) Tate
  4. Editorial
  5. The long way to standardization of practices: HbA1c as archetypal example
  6. Reviews
  7. Secretory tumors of the pituitary gland: a clinical biochemistry perspective
  8. Thalassemia in the laboratory: pearls, pitfalls, and promises
  9. Opinion Paper
  10. Diagnostic biomarkers of muscle injury and exertional rhabdomyolysis
  11. General Clinical Chemistry and Laboratory Medicine
  12. Patient’s knowledge and awareness about the effect of the over-the-counter (OTC) drugs and dietary supplements on laboratory test results: a survey in 18 European countries
  13. National surveys on 15 quality indicators for the total testing process in clinical laboratories of China from 2015 to 2017
  14. Urinary albumin strip assay as a screening test to replace quantitative technology in certain conditions
  15. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis
  16. Different immunoreactivity of monomers and dimers makes automated free light chains assays not equivalent
  17. The utility of saliva testing in the estimation of uremic toxin levels in serum
  18. Determination of cannabinoids in oral fluid and urine of “light cannabis” consumers: a pilot study
  19. Moving from the second to the third generation Roche PTH assays: what are the consequences for clinical practice?
  20. Baseline hepcidin measurement in the differential diagnosis of anaemia for elderly patients and its correlation with the increment of transferrin saturation following an oral iron absorption test
  21. Reference Values and Biological Variations
  22. A multicenter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study)
  23. Cancer Diagnostics
  24. Urinary measurement of circulating tumor DNA for treatment monitoring and prognosis of metastatic colorectal cancer patients
  25. BCL2L12: a multiply spliced gene with independent prognostic significance in breast cancer
  26. Diabetes
  27. The global impact of the International Federation of Clinical Chemistry and Laboratory Medicine, Education and Management Division: engaging stakeholders and assessing HbA1c quality in a multicentre study across China
  28. The frequency of testing for glycated haemoglobin, HbA1c, is linked to the probability of achieving target levels in patients with suboptimally controlled diabetes mellitus
  29. Letters to the Editor
  30. Response to article by Caponi et al. about serum free light chains
  31. Response to Letter to the Editor about immunochemical measurement of urine free light chains
  32. Estimated GFR-specific 99th percentiles for high-sensitive cardiac troponin T based on the adjusted analytical change limit (adjACL) in hospitalized patients
  33. Perioperative heart-type fatty acid binding protein concentration cutoffs for the identification of severe acute kidney injury in patients undergoing cardiac surgery
  34. A peculiar reaction curve with dual spikes in absorbance during a total bilirubin assay in spite of accurate results induced by high M-protein concentration
  35. Extremely low high-density-lipoprotein cholesterol due to an unusual non-inherited cause: a case report
  36. A single-center performance evaluation of the fully automated iFlash anti-Müllerian hormone immunoassay
  37. Genetic polymorphisms and variants in the LDL receptor associated with familial hypercholesterolemia: cascade screening and identification of the variants 666C>A, 862G>A, 901G>A, and 919G>A of a Brazilian family
  38. Undetected paraganglioma by functional imaging techniques: case report
  39. A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene
  40. Atypical “hairy cell-like” presentation of leukemic mantle cell lymphoma
  41. Evaluation of a rapid centrifugation step (4500 g for 2 min) in coagulation assays to monitor direct oral anticoagulants
Downloaded on 17.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2018-2394/html
Scroll to top button